Search ( 33934 results )
- article
(Updated on )
The prevalence of viral markers among unpaid blood donors in Europe declined between 1990 and 1996. Eurosynthèse
In Europe, nonprofit plasma fractionation organizations believe that standardized epidemiological data collection and analysis is a key public health issue. These organizations are...
- article
(Updated on )
Epidemiological surveillance of homologous blood donors and residual risk in France between 2003 and 2005. Regular surveillance reports - Infectious diseases
Introduction - The national epidemiological surveillance of blood donors aims to monitor the prevalence and incidence of bloodborne infections (HIV, HTLV, HCV, and HBV), identify risk...
- article
(Updated on )
Impact of Excluding Donors Who Have Stayed in the British Isles on the Residual Risk of HIV Transmission Through Transfusion of Labile Blood Products
Objective. Among the measures likely to reduce the risk of transmission of the agent causing the new variant of Creutzfeldt-Jakob disease, excluding blood donations from donors who had...
- article
(Updated on )
Screening for markers of transfusion-transmissible infections in blood donations collected in France from 1996 to 1998
From 1996 to 1998, a decline in the rates of donations testing positive for the human immunodeficiency virus (HIV), hepatitis C virus (HCV), and hepatitis B surface antigen (HBsAg) was...
- article
(Updated on )
Changes in the residual risk of viral infection transmission through blood transfusion between 1992 and 2001 in France and the impact of DGV
This study analyzes trends in the residual risk of transmission of HIV, HBV, and HCV through blood transfusion over eight three-year periods from 1992 to 2001 and compares, for HIV and...
- report/summary
(Updated on )
Quantitative Estimation of the Risk of Blood Donation Contamination by Infectious Agents. Working Group of Afssaps, EFS, INTS, and InVS
The presence of asymptomatic shedding of certain infectious agents in the bloodstream poses a risk of transmission of these agents during blood transfusions. While this risk is currently...
(Updated on )
HIV Surveillance Among Allogeneic Blood Donors. The Fight Against HIV/AIDS and Sexually Transmitted Infections in France: 10 Years of Surveillance, 1996–2005
- A decline in HIV prevalence among blood donors through 1998, followed by stabilization at around 0.5 per 10,000 new donors between 1998 and 2005. - Stability in HIV incidence among...
- article
(Updated on )
HIV-positive status among blood donors from 1985 to 1989
- report/summary
(Updated on )
Epidemiological surveillance of allogeneic blood donors in France between 1992 and 2002
Epidemiological surveillance of blood donors began in France in 1985 with the introduction of mandatory HIV screening for blood donations. The purpose of this report is to present all...
- article
(Updated on )
Residual risk of HIV, HCV, and HBV transmission through blood transfusion in France between 1992 and 2002 and the impact of viral genomic testing
The objective of this article is to analyze trends in the residual risk of HIV transmission, HCV, and HBV, over nine three-year periods from 1992–1994 to 1999–2002 and, for HIV and HCV,...
